Clinical trial
Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating…
NCT00016315 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00016315 |
|---|---|
| Title | Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer |
| Official title | A Phase I Study of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Radiation Therapy Followed by Adjuvant Chemotherapy for Patients With Favorable Prognosis Inoperable Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, gemcitabine hydrochloride, paclitaxel, radiation therapy |
| Enrollment | 35 |
| Start date | May 1, 2001 |
| Primary completion | Jan 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | May 7, 2003 |
| Last update posted | Nov 17, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: